| Bioactivity | HIV-1 protease-IN-5 (Compound 13c) is a HIV-1 protease inhibitor with an IC50 of 1.64 nM. HIV-1 protease-IN-5 shows remarkable activity against wild-type and DRV-resistant HIV-1 variants[1]. |
| Target | IC50: 1.64 nM (HIV-1 protease) |
| Name | HIV-1 protease-IN-5 |
| CAS | 2525173-96-8 |
| Formula | C27H29F3N2O7S |
| Molar Mass | 582.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhu M, et al. Design and biological evaluation of novel HIV-1 protease inhibitors with isopropanol as P1' ligand to enhance binding with S1' subsite. Bioorg Med Chem. 2020 Aug 15;28(16):115623. |
HIV-1 protease-IN-5
CAS: 2525173-96-8 F: C27H29F3N2O7S W: 582.59
HIV-1 protease-IN-5 (Compound 13c) is a HIV-1 protease inhibitor with an IC50 of 1.64 nM. HIV-1 protease-IN-5 shows rema
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.